
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.920 | 4.070 | 0.150 |
Shares | 96.080 | 96.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 39.371 | 34.495 |
Price to Book | 5.338 | 5.006 |
Price to Sales | 6.156 | 5.004 |
Price to Cash Flow | 29.110 | 23.656 |
Dividend Yield | 0.569 | 0.655 |
5 Years Earnings Growth | 17.445 | 14.104 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.740 | 96.226 |
Basic Materials | 6.260 | 4.978 |
Number of long holdings: 31
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12.73 | 1,727.70 | +2.68% | |
Divi's Labs | INE361B01024 | 7.39 | 6,780.00 | +0.02% | |
Max Healthcare Institute | INE027H01010 | 6.40 | 1,261.00 | +0.91% | |
Lonza Group AG | US54338V1017 | 4.81 | 70.66 | -0.08% | |
Cipla | INE059A01026 | 4.77 | 1,492.00 | +0.54% | |
Lupin | INE326A01037 | 4.46 | 1,956.50 | +1.58% | |
Mankind Pharma | INE634S01028 | 3.75 | 2,652.20 | -1.76% | |
Krishna Institute of Medical Sciences | INE967H01025 | 3.34 | 715.00 | +0.66% | |
Fortis Healthcare | INE061F01013 | 3.22 | 799.00 | +2.13% | |
Acutaas Chemicals | INE00FF01025 | 3.19 | 1,194.00 | +3.99% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Reg Div Payout | 787.08B | 11.12 | 17.81 | 12.40 | ||
SBI Magnum Balanced Fund Direct Div | 787.08B | 11.48 | 18.61 | 13.33 | ||
SBI Magnum Balanced Fund Direct Gro | 787.08B | 11.48 | 18.61 | 13.42 | ||
SBI Magnum Balanced Fund Regular Gr | 787.08B | 11.12 | 17.81 | 12.48 | ||
SBI Blue Chip Fund Direct Dividend | 539.59B | 7.57 | 20.06 | 13.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review